The Impact of COVID-19 is included in Mumps Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Mumps Vaccine Trends and Forecast
The future of the global mumps vaccine market looks promising with opportunities in the pediatric clinic, hospital, and NGO markets. The global mumps vaccine market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 8.6% from 2024 to 2030. The major drivers for this market are high prevalence and morbidity of mumps infection, growing demand for efficient and safe mumps vaccines, and rising government support for mumps vaccination programs.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Mumps Vaccine by Segment
The study includes a forecast for the global mumps vaccine by product type, age group, end use, and region.
Mumps Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
• Monovalent
• Combinational
• Divalent
• Trivalent
• Others
Mumps Vaccine Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:
• Pediatric
• Adult
Mumps Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Pediatric Clinic
• Hospitals
• NGOs
• Others
Mumps Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Mumps Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mumps vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mumps vaccine companies profiled in this report include-
• MedImmune
• Johnson & Johnson
• Merck
• Sanofi
• Serum Institute of India
• Bavarian Nordic
• Astellas Pharma India
• CSL
• Emergent Biosolutions
• GlaxoSmithKline
Mumps Vaccine Market Insights
Lucintel forecasts that combinational is expected to witness highest growth over the forecast period due to its advatages like convenience and cost-effectiveness.
Within this market, pediatric clinic will remain the largest segment due to significant application of mumps vaccine among children.
North America is expected to witness highest growth over the forecast period.
Features of the Global Mumps Vaccine Market
Market Size Estimates: Mumps vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Mumps vaccine market size by product type, age group, end use, and region in terms of value ($B).
Regional Analysis: Mumps vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, age groups, end uses, and regions for the mumps vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mumps vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the mumps vaccine market size?
Answer: The global mumps vaccine market is expected to reach an estimated $1.1 billion by 2030.
Q.2 What is the growth forecast for mumps vaccine market?
Answer: The global mumps vaccine market is expected to grow with a CAGR of 8.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the mumps vaccine market?
Answer: The major drivers for this market are high prevalence and morbidity of mumps infection, growing demand for efficient and safe mumps vaccines, and rising government support for mumps vaccination programs.
Q4. What are the major segments for mumps vaccine market?
Answer: The future of the mumps vaccine market looks promising with opportunities in the pediatric clinic, hospital, and NGO markets.
Q5. Who are the key mumps vaccine market companies?
Answer: Some of the key mumps vaccine companies are as follows:
• MedImmune
• Johnson & Johnson
• Merck
• Sanofi
• Serum Institute of India
• Bavarian Nordic
• Astellas Pharma India
• CSL
• Emergent Biosolutions
• GlaxoSmithKline
Q6. Which mumps vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that combinational is expected to witness highest growth over the forecast period due to its advatages like convenience and cost-effectiveness.
Q7. In mumps vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the mumps vaccine market by product type (monovalent, combinational, divalent, trivalent, and others), age group (pediatric and adult), end use (pediatric clinic, hospitals, NGOs, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Mumps Vaccine Market, Mumps Vaccine Market Size, Mumps Vaccine Market Growth, Mumps Vaccine Market Analysis, Mumps Vaccine Market Report, Mumps Vaccine Market Share, Mumps Vaccine Market Trends, Mumps Vaccine Market Forecast, Mumps Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Mumps Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Mumps Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Mumps Vaccine Market by Product Type
3.3.1: Monovalent
3.3.2: Combinational
3.3.3: Divalent
3.3.4: Trivalent
3.3.5: Others
3.4: Global Mumps Vaccine Market by Age Group
3.4.1: Pediatric
3.4.2: Adult
3.5: Global Mumps Vaccine Market by End Use
3.5.1: Pediatric Clinic
3.5.2: Hospitals
3.5.3: NGOs
3.5.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Mumps Vaccine Market by Region
4.2: North American Mumps Vaccine Market
4.2.2: North American Mumps Vaccine Market by End Use: Pediatric Clinic, Hospitals, NGOs, and Others
4.3: European Mumps Vaccine Market
4.3.1: European Mumps Vaccine Market by Product Type: Monovalent, Combinational, Divalent, Trivalent, and Others
4.3.2: European Mumps Vaccine Market by End Use: Pediatric Clinic, Hospitals, NGOs, and Others
4.4: APAC Mumps Vaccine Market
4.4.1: APAC Mumps Vaccine Market by Product Type: Monovalent, Combinational, Divalent, Trivalent, and Others
4.4.2: APAC Mumps Vaccine Market by End Use: Pediatric Clinic, Hospitals, NGOs, and Others
4.5: ROW Mumps Vaccine Market
4.5.1: ROW Mumps Vaccine Market by Product Type: Monovalent, Combinational, Divalent, Trivalent, and Others
4.5.2: ROW Mumps Vaccine Market by End Use: Pediatric Clinic, Hospitals, NGOs, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Mumps Vaccine Market by Product Type
6.1.2: Growth Opportunities for the Global Mumps Vaccine Market by Age Group
6.1.3: Growth Opportunities for the Global Mumps Vaccine Market by End Use
6.1.4: Growth Opportunities for the Global Mumps Vaccine Market by Region
6.2: Emerging Trends in the Global Mumps Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Mumps Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Mumps Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: MedImmune
7.2: Johnson & Johnson
7.3: Merck
7.4: Sanofi
7.5: Serum Institute of India
7.6: Bavarian Nordic
7.7: Astellas Pharma India
7.8: CSL
7.9: Emergent BioSolutions
7.10: GlaxoSmithKline
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Mumps Vaccine Market Report.